Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Schizophr Res. 2013 Jul 23;149(0):10.1016/j.schres.2013.07.008. doi: 10.1016/j.schres.2013.07.008

Table 1.

Sample Characteristics

Treatment Sample
Size		 Mean Baseline(SD)* Mean AGE (SD)** # of
Females** 		# of
Males**
Olanzapine 134 73.5 (18.8) 40.5 (11.6) 34 100
Quetiapine 124 73.5 (18.0) 40.5 (11.2) 29 95
Risperidone 134 77.5 (17.2) 42.2 (11.4) 29 105
Ziprasidone 74 71.3 (16.2) 40.1 (11.1) 21 53
*

Baseline PANSS was a significant contributor to drug response and therefore was incorporated into the mixed model that provided the response variable used for the genetic analysis;

**

Both sex and age were considered for inclusion in the response model; however as they did not significantly contribute to response they were not included in the final mixed model.